Featured Research

from universities, journals, and other organizations

New Drug Abuse Treatment Shows Promise

Date:
July 12, 2005
Source:
Yale University
Summary:
Patients who receive buprenorphine treatment for opioid addiction in an office--based setting are more likely than those receiving methadone treatment to be young men, new to drug use, and with no history of methadone treatment, Yale School of Medicine researchers report in a study published in Drug and Alcohol Dependence.

New Haven, Conn. -- Patients who receive buprenorphine treatment for opioid addiction in an office--based setting are more likely than those receiving methadone treatment to be young men, new to drug use, and with no history of methadone treatment, Yale School of Medicine researchers report in a study published in Drug and Alcohol Dependence.

Approved for treating heroin and prescription opiate pain killer abuse in 2002, office--based buprenorphine holds the promise of bringing new patients into treatment. While heroin and prescription opiate pain killer abuse has substantially increased over the years, the availability of treatment has not increased with the demand.

Along with her colleagues, Lynn Sullivan, M.D., assistant professor of internal medicine at Yale School of Medicine, evaluated whether office--based buprenorphine treatment in a primary care clinic was associated with a different patient population receiving treatment compared to patients enrolling in methadone maintenance.

"We found that individuals seeking buprenorphine did differ from those seeking methadone along several important variables--age, sex, ethnicity, employment status, etc.," said Sullivan. " Results suggest that buprenorphine is having some success in reaching individuals who are unable or unwilling to use methadone for opioid addiction."

Demographic information and the individual's history of drug abuse were compiled from 190 patients seeking treatment for opioid addiction.

Individuals that received buprenorphine, compared to those that sought out methadone treatment, were more likely to be male, employed, have five fewer years of opioid addiction, have lower rates of injection drug use, lower rates of hepatitis C infection and have no prior history of methadone treatment.

Other authors on the study included Marek Chawarski, Patrick G. O'Connor, Richard S. Schottenfeld and David A. Fiellin.

###

Citation: Drug and Alcohol Dependence, 79, 113--116 (July 2005).


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "New Drug Abuse Treatment Shows Promise." ScienceDaily. ScienceDaily, 12 July 2005. <www.sciencedaily.com/releases/2005/07/050710202753.htm>.
Yale University. (2005, July 12). New Drug Abuse Treatment Shows Promise. ScienceDaily. Retrieved August 28, 2014 from www.sciencedaily.com/releases/2005/07/050710202753.htm
Yale University. "New Drug Abuse Treatment Shows Promise." ScienceDaily. www.sciencedaily.com/releases/2005/07/050710202753.htm (accessed August 28, 2014).

Share This




More Mind & Brain News

Thursday, August 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Alice in Wonderland Syndrome

Alice in Wonderland Syndrome

Ivanhoe (Aug. 27, 2014) It’s an unusual condition with a colorful name. Kids with “Alice in Wonderland” syndrome see sudden distortions in objects they’re looking at or their own bodies appear to change size, a lot like the main character in the Lewis Carroll story. Video provided by Ivanhoe
Powered by NewsLook.com
Stopping Schizophrenia Before Birth

Stopping Schizophrenia Before Birth

Ivanhoe (Aug. 27, 2014) Scientists have long called choline a “brain booster” essential for human development. Not only does it aid in memory and learning, researchers now believe choline could help prevent mental illness. Video provided by Ivanhoe
Powered by NewsLook.com
Personalized Brain Vaccine for Glioblastoma

Personalized Brain Vaccine for Glioblastoma

Ivanhoe (Aug. 27, 2014) Glioblastoma is the most common and aggressive brain cancer in humans. Now a new treatment using the patient’s own tumor could help slow down its progression and help patients live longer. Video provided by Ivanhoe
Powered by NewsLook.com
Brain Surgery in 3-D

Brain Surgery in 3-D

Ivanhoe (Aug. 27, 2014) Neurosurgeons now have a new approach to brain surgery using the same 3D glasses you’d put on at an IMAX movie theater. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins